| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 668432 | Null | 0.0115521552688258 | -0.11732466 |
| NSC 671119 | Null | 0.0115521552688258 | 0.48415434 |
| NSC 671660 | Null | 0.0115521552688258 | 0.24322871 |
| NSC 677959 | 16.beta.-N-methylpiperazino-5-androstene-3.beta.,17.beta.-diol | 0.0115521552688258 | 0.10706916 |
| NSC 683332 | Spiro[2a,8a-epoxyanthra[2,3-b]oxirene- 2-(1aH),2'-naphtho[1,8-de][1,3]dioxin]-3,8(9H,9aH)-dione, 9-hydroxy-, stereoisomer | 0.0115521552688258 | 0.36110269 |
| NSC 692582 | Null | 0.0115521552688258 | 0.35969094 |
| NSC 693547 | 2-Amino-4-(2-hydroxy-4-methylphenyl)-5-phenylpyrimidine | 0.0115521552688258 | 0.52897064 |
| NSC 694269 | Benzimidazo[1,2-a][1,8]naphthyridin-7-ium, 6-cyano-5-[[2-(3-methoxyphenyl)ethyl]amino]- 7-methyl-, 4-methylbenzenesulfonate | 0.0115521552688258 | 0.12900673 |
| NSC 123491 | L-Cysteine, S-[tris(4-methylphenyl)methyl]- (9CI) | 0.0137568419586474 | 0.046217676 |
| NSC 343378 | 1H-Indene-1,3(2H)-dione, 2-[[(2-methylphenyl)imino]phenylmethyl]- | 0.0137568419586474 | 0.11318227 |